ABSTRACT
Today our whole world is entangled with the most dreadful disease Corona which is caused by the successor of SARS known as SARS-Cov-2 virus. Coronavirus is the influenza-like respiratory disease causing damage to the respiratory system of the humans through the ACE2 receptors which acts as an entry gate for the virus to enter. The Corona virus was identified in late 2019 in the city of Wuhan, China which later spread to the most of the territories in China. The spread was first identified by the Bluedot which is a Saas service designed to track and detect the spread of infectious disease. When the other countries came to know the severity of the virus they made various steps to prevent the spread of the virus. The initial symptoms of coronavirus are rise in temperature, loss of taste and smell and short breathness. As the entry level check many institutions and offices, checks the body temperature of the people and checks whether the person is wearing a mask or not. To make this process fully automatic without human intervention the use of AI enabled IR camera sensor with the Arduino UNO is made. The detection of temperature can be made possible by the use of the computer leveraging vision techniques which is equipped with the Raspberry-pi camera module. The process is based on the thermal imaging of the person which can detect the elevated temperature of the person and prevents them from entering into the institution or offices thereby the spread due to the possibly affected persons can be avoided thereby the spread can be controlled. The system not only identifies the person with high temperature but also checks whether the person is wearing a mask or not. The real time analysis of the system is the major advantage of the proposed system.
ABSTRACT
Coronavirus is a vast group of infections known to cause disease that change between the normal cold and most extreme illness to include Severe Acute Respiratory Syndrome (SARS) known as the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the resulting disease is recognized as COVID-19. A tale Covid-19 was distinguished in December 2019 in Wuhan City, Hubei territory, China. The frequency of Covid-19 continues to increase, because of global protection and isolated activities. Because of the outbreak of Covid-19 (SARS-CoV-2) specialists and pharmaceutical companies are quickly searching for antiviral therapies ready to mitigate the manifestation of the disease. There is no clinically endorsed antiviral drug to be utilized against Covid-19. In the current review, encapsulate the conditions of details about therapeutic agents to treat Covid-19 and its adverse effects in forthcoming clinical trials. This review anticipates that the analysis of the current and emerging research in clinical studies of therapeutic agent will lead to the advancement of future research. [ABSTRACT FROM AUTHOR] Copyright of Trends in Biomaterials & Artificial Organs is the property of Society for Biomaterials & Artificial Organs, India and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)